Care Delivery

This channel includes news on cardiovascular care delivery, including how patients are diagnosed and treated, cardiac care guidelines, policies or legislation impacting patient care, device recalls that may impact patient care, and cardiology practice management.

Thumbnail

TAVR linked to favorable outcomes for asymptomatic and minimally symptomatic patients—but is it necessary?

While TAVR is safe for minimally symptomatic patients, questions remain about whether or not it is actually needed. A new analysis in JACC: Cardiovascular Interventions examines this topic in detail.

artificial intelligence in healthcare

Industry Watcher’s Digest

Buzzworthy developments of the past few days.

africa looks to artificial intelligence for healthcare improvement

Overheard in Africa: AI may be just what the doctor ordered for better healthcare, stronger society

Technology leaders and academic researchers joined with healthcare professionals in Nigeria Nov. 13 to sketch out the future of African healthcare.

FDA announces recall of more than 32 million disposable syringes

The new-look syringes are causing significant issues when used with syringe infusion pumps. This is a Class I recall, which means the FDA believes the products “may cause serious injuries or death.”

hospital price transparency

Even facing hefty fines, many hospitals punt on price transparency. Why is that?

Seeking to uncover the rationale driving hospitals to flout compliance, researchers interviewed hospital informants at 12 nonprofit institutions.

Maya Kowalski case

‘Take Care of Maya’ protagonist ups ante with criminal charge

Less than a week after the famous Kowalski family won a $261 million civil judgment against a Johns Hopkins facility in Florida, Maya Kowalski is announcing she will slap the hospital with a criminal complaint alleging sexual assault.

doctor telehealth computer screen

Amazon expands telehealth presence, offers primary care for $9 a month

Televisits will cost $9 a month or $99 per year and are facilitated by One Medical. 

TAVR utilization skyrocketed over 5-year period, improving survival for older AS patients

The study focused on patients 65 years old and older who underwent treatment in one of 21 high-income countries.